Maurel Blandine, Martin-Gonzalez Teresa, Chong Debra, Irwin Andrew, Guimbretière Guillaume, Davis Meryl, Mastracci Tara M
Aortic Team, Vascular Surgery Directorate, The Royal Free London, London, United Kingdom; Department of Vascular Surgery, Institut du Thorax, CHU Nantes, Nantes, France.
Aortic Team, Vascular Surgery Directorate, The Royal Free London, London, United Kingdom.
J Vasc Surg. 2018 Dec;68(6):1706-1713.e1. doi: 10.1016/j.jvs.2018.04.015. Epub 2018 May 24.
Use of three-dimensional fusion has been shown to significantly reduce radiation exposure and contrast material use in complex (fenestrated and branched) endovascular aneurysm repair (EVAR). Cydar software (CYDAR Medical, Cambridge, United Kingdom) is a cloud-based technology that can provide imaging guidance by overlaying preoperative three-dimensional vessel anatomy from computed tomography scans onto live fluoroscopy images both in hybrid operating rooms and on mobile C-arms. The aim of this study was to determine whether radiation dose reduction would occur with the addition of fusion imaging to infrarenal repair in all imaging environments.
All patients who consented to involvement in the trial and who were treated with EVAR in our center from March 2016 until April 2017 were included. A teaching session about radiation protection and Cydar fusion software use was provided to all operators before the start of the fusion group enrollment. This group was compared with a retrospective cohort of patients treated in the same center from March 2015 to March 2016, after a dedicated program of radiation awareness and reduction was introduced. Ruptured aneurysms and complex EVAR were excluded. Preoperative and perioperative characteristics were recorded, including parameters of radiation dose, such as air kerma and dose-area product. Results were expressed in median and interquartile range.
Forty-four patients were prospectively enrolled and compared with 21 retrospective control patients. No significant differences were found in comparing sex, body mass index, and age at repair. The median operation time (wire to wire) and fluoroscopy time were 90 (75-105) minutes and 30 (22-34) minutes, respectively, without significant differences between groups (P = .56 and P = .36). Dose-area product was nonsignificantly higher in the control group, 21.7 (8.9-85.9) Gy cm, compared with the fusion group, 12.4 (7.5-23.4) Gy cm (P = .10). Air kerma product was significantly higher in the control group, 142 (61-541) mGy, compared with 82 (51-115) mGy in the fusion group (P = .03). The number of digital subtraction angiography runs was significantly lower in the fusion group (8 [6-11]) compared with the control group (10 [9-14]); (P = .03). There were no significant differences in the frequency of adverse events, endoleaks, or additional procedures required.
When it is used in simple procedures such as infrarenal aneurysm repair, image-based fusion technology is feasible both in hybrid operating rooms and on mobile systems and leads to an overall 50% reduction in radiation dose. Fusion technology should become standard of care for centers attempting to maximize radiation dose reduction, even if capital investment of a hybrid operating room is not feasible.
三维融合技术已被证明可显著减少复杂(开窗和分支)血管内动脉瘤修复术(EVAR)中的辐射暴露和造影剂使用。Cydar软件(CYDAR Medical,英国剑桥)是一种基于云的技术,可通过将术前计算机断层扫描的三维血管解剖结构叠加到杂交手术室和移动C形臂的实时荧光透视图像上,提供成像指导。本研究的目的是确定在所有成像环境下,在肾下修复术中增加融合成像是否会降低辐射剂量。
纳入2016年3月至2017年4月在本中心同意参与试验并接受EVAR治疗的所有患者。在融合组入组前,为所有操作人员提供了一次关于辐射防护和Cydar融合软件使用的培训课程。将该组与2015年3月至2016年3月在同一中心接受治疗的患者回顾性队列进行比较,此前已引入了一项专门的辐射意识和减少计划。排除破裂动脉瘤和复杂的EVAR。记录术前和围手术期特征,包括辐射剂量参数,如空气比释动能和剂量面积乘积。结果以中位数和四分位数间距表示。
前瞻性纳入44例患者,并与21例回顾性对照患者进行比较。在比较性别、体重指数和修复时年龄方面未发现显著差异。中位手术时间(导丝到导丝)和透视时间分别为90(75-105)分钟和30(22-34)分钟,两组之间无显著差异(P = 0.56和P = 0.36)。对照组的剂量面积乘积略高于融合组,分别为21.7(8.9-85.9)Gy cm和12.4(7.5-23.4)Gy cm(P = 0.10)。对照组的空气比释动能乘积显著高于融合组,分别为142(61-541)mGy和82(51-115)mGy(P = 0.03)。融合组的数字减影血管造影运行次数显著低于对照组(8 [6-11])与对照组(10 [9-14]);(P = 0.03)。不良事件、内漏或所需额外手术的发生率无显著差异。
当用于肾下动脉瘤修复等简单手术时,基于图像的融合技术在杂交手术室和移动系统中都是可行的,并且可使辐射剂量总体降低50%。对于试图最大限度降低辐射剂量的中心,即使杂交手术室的资本投资不可行,融合技术也应成为护理标准。